These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2471088)

  • 1. Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths.
    Menke G; Wörner W; Kratzer W; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):42-7. PubMed ID: 2471088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of free fatty acids on the binding kinetics at the benzodiazepine binding site of glycated human serum albumin.
    Keita Y; Kratzer W; Wörner W; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):337-42. PubMed ID: 7690351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependence and free fatty acid modulation of binding kinetics at the benzodiazepine binding site of serum albumin in neonates and adults determined using fast reaction methods.
    Menke G; Pfister P; Sauerwein S; Rietbrock I; Woodcock BG; Rietbrock N
    Br J Clin Pharmacol; 1987 Apr; 23(4):439-45. PubMed ID: 2437944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of non-steroidal anti-inflammatory drugs on the binding kinetics of dansylsarcosine to human serum albumin. Stereoselectivity, steric and inductive effects.
    Keita Y; Wörner W; Veile G; Woodcock BG; Fuhr U
    Arzneimittelforschung; 1996 Feb; 46(2):164-8. PubMed ID: 8720306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR; Yates MS; Bowmer CJ
    Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-enzymatic glycation of human serum albumin: influence on thebinding kinetics of the benzodiazepine binding sites].
    Wörner W; Pfleiderer S; Kratzer W; Rietbrock N
    J Clin Chem Clin Biochem; 1990 Aug; 28(8):527-31. PubMed ID: 1701826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-protein binding kinetics in patients with type I diabetes.
    Wörner W; Preissner A; Rietbrock N
    Eur J Clin Pharmacol; 1992; 43(1):97-100. PubMed ID: 1380461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of free fatty acid effect on methotrexate binding to albumin.
    Claudepierre P; Urien S; Chassany O; Tillement JP
    Biochem Pharmacol; 1994 Jan; 47(2):415-7. PubMed ID: 8304986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR; Bowmer CJ; Yates MS
    Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.
    Richieri GV; Anel A; Kleinfeld AM
    Biochemistry; 1993 Jul; 32(29):7574-80. PubMed ID: 8338853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of free fatty acids on the binding of bovine and human serum albumin with steroid hormones.
    Watanabe S; Sato T
    Biochim Biophys Acta; 1996 Apr; 1289(3):385-96. PubMed ID: 8620023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H-NMR study on the interactions of human serum albumin with free fatty acid.
    Oida T
    J Biochem; 1986 Dec; 100(6):1533-42. PubMed ID: 3571185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fatty acid chain length and thioesterification on the augmentation of expression of plasminogen activator inhibitor-1.
    Chen Y; Sobel BE; Schneider DJ
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):325-30. PubMed ID: 12669679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel binding site for bile acids on human serum albumin.
    Takikawa H; Sugiyama Y; Hanano M; Kurita M; Yoshida H; Sugimoto T
    Biochim Biophys Acta; 1987 Nov; 926(2):145-53. PubMed ID: 2444264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells. I. Saturated long-chain fatty acids.
    Wenzel DG; Hale TW
    Toxicology; 1978 Oct; 11(2):109-17. PubMed ID: 715796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of free fatty acid concentration on furosemide binding to human serum albumin.
    Schwartz PA; Rhodes CT; Greene DS
    Pharmacology; 1981; 22(6):364-70. PubMed ID: 7267702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
    Thumser AE; Buckland AG; Wilton DC
    J Lipid Res; 1998 May; 39(5):1033-8. PubMed ID: 9610770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids.
    Patel IH; Levy RH
    Epilepsia; 1979 Feb; 20(1):85-90. PubMed ID: 369855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin.
    Mendel CM; Frost PH; Cavalieri RR
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1394-9. PubMed ID: 3782424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.